DI IOIA, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 2.437
EU - Europa 1.638
AS - Asia 1.447
SA - Sud America 151
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 6
Totale 5.706
Nazione #
US - Stati Uniti d'America 2.397
SG - Singapore 511
CN - Cina 467
DE - Germania 243
IE - Irlanda 226
IT - Italia 220
UA - Ucraina 182
GB - Regno Unito 168
TR - Turchia 159
SE - Svezia 146
RU - Federazione Russa 142
BR - Brasile 130
VN - Vietnam 129
FI - Finlandia 112
FR - Francia 112
IN - India 68
CA - Canada 33
HK - Hong Kong 20
CZ - Repubblica Ceca 18
BE - Belgio 12
JP - Giappone 12
PL - Polonia 12
BD - Bangladesh 11
IQ - Iraq 10
NL - Olanda 10
ZA - Sudafrica 9
PK - Pakistan 8
CH - Svizzera 7
ES - Italia 7
EU - Europa 7
AR - Argentina 6
AU - Australia 6
ID - Indonesia 6
MX - Messico 6
SA - Arabia Saudita 6
JO - Giordania 5
RS - Serbia 5
AE - Emirati Arabi Uniti 4
IR - Iran 4
KR - Corea 4
MA - Marocco 4
PH - Filippine 4
VE - Venezuela 4
MY - Malesia 3
PY - Paraguay 3
UZ - Uzbekistan 3
AM - Armenia 2
AT - Austria 2
CL - Cile 2
DK - Danimarca 2
GR - Grecia 2
HR - Croazia 2
IL - Israele 2
KE - Kenya 2
KZ - Kazakistan 2
NP - Nepal 2
PE - Perù 2
RO - Romania 2
TN - Tunisia 2
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EG - Egitto 1
ET - Etiopia 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
OM - Oman 1
PT - Portogallo 1
SR - Suriname 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 5.706
Città #
Singapore 381
Chandler 288
Jacksonville 251
Dublin 223
San Jose 194
Ashburn 184
Dallas 168
Beijing 141
Munich 139
Southend 116
Princeton 94
The Dalles 88
Nanjing 85
Ann Arbor 76
Izmir 73
Chieti 71
Dearborn 62
New York 60
Los Angeles 57
Helsinki 53
Ho Chi Minh City 47
Santa Clara 47
Wilmington 40
Cambridge 39
Altamura 32
Nanchang 29
Moscow 28
Tongling 27
Hanoi 26
Boardman 21
Hong Kong 18
São Paulo 18
Washington 18
Woodbridge 18
Frankfurt am Main 17
Turku 17
Redondo Beach 16
Grevenbroich 15
Montreal 15
Brno 14
Buffalo 14
Kunming 14
Shenyang 13
Brussels 12
Denver 12
Guangzhou 12
Jiaxing 12
London 12
Hebei 11
Norwalk 11
Orem 11
Tianjin 11
Tokyo 11
Amsterdam 10
Atlanta 9
Hangzhou 9
Houston 9
Stockholm 9
Toronto 9
Warsaw 9
Baghdad 8
San Francisco 8
San Mateo 8
Brooklyn 7
Changsha 7
Council Bluffs 7
Fermo 7
Monmouth Junction 7
Nuremberg 7
Phoenix 7
Chennai 6
Dong Ket 6
Falls Church 6
Fribourg 6
Jinan 6
Lanzhou 6
Poplar 6
Amman 5
Belgrade 5
Camerino 5
Manchester 5
Mumbai 5
Pescara 5
Roseto Degli Abruzzi 5
Seattle 5
Ankara 4
Boston 4
Changchun 4
Curitiba 4
Da Nang 4
Edinburgh 4
Hanover 4
Johannesburg 4
Montesilvano Marina 4
Olomouc 4
Rome 4
San Vito Chietino 4
Teramo 4
Zhengzhou 4
Ardabil 3
Totale 3.740
Nome #
Enhanced release of acid sphingomyelinase-enriched exosomes generates a lipidomics signature in CSF of Multiple Sclerosis patients 344
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis 214
Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid 184
Integration of metabolomics and proteomics in multiple sclerosis: from biomarkers discovery to personalized medicine 165
Cleavage of cystatin C is not associated with multiple sclerosis 165
Metabolomic Signature in Sera of Multiple Sclerosis Patients during Pregnancy 159
A lipidomic investigation for the caracterisation of CSF lipid profile in patients with multiple sclerosis 159
Increasing age at disability milestones among MS patients in the MSBase Registry 152
The Multiple Sclerosis Knowledge Questionnaire: a self administered instrument for recently diagnosed patients 147
Alemtuzumab treatment of multiple sclerosis in real-world clinical practice: A report from a single Italian center 147
UNRAVELING THE MOLECULAR REPERTOIRE OF TEARS AS A SOURCE OF BIOMARKERS: BEYOND OCULAR DISEASES 144
Contribution of metabolomics to multiple sclerosis diagnosis, prognosis and treatment 139
Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis. 138
Data of safety in a single-center alemtuzumab treated population 138
Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients 137
An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care. 137
Acetylcholine in multiple sclerosis: possible involvement in the modulation of the immune response and in oligodendrocyte recruitment. 134
Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis 134
Convulsive status epilepticus due to new encephalic demyelinating lesions in multiple sclerosis 133
A difficult pediatric case: ADEM evolving in multiple sclerosis complicated by progressive multifocal leukoencephalopathy after Natalizumab treatment. 131
Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis. 131
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. 125
TLC-MALDI-Imaging approach for lipidomics studies in cerebrospinal fluid reveals low levels of sphingomyelin in multiple sclerosis patients 124
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. 122
JCV-Ab serostatus in MS patients treated with Natalizumab 121
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 121
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy. 120
Nail loss after teriflunomide treatment: a new potential adverse event 114
Mass spectrometry based metabonomics of the cerebrospinalfluid highlights a correlation between polar lipids and carnitines levels in multiple sclerosis patients. 113
OXIDATIVE MODIFICATIONS OF CEREBRAL TRANSTHYRETIN ARE ASSOCIATED WITH MULTIPLE SCLEROSIS 112
Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group 111
Multiphasic Adem or Multiple Sclerosis? Treatement implications. 111
Natalizumab-associated PML-IRIS: the Chieti experience. 110
Neuropsychological testing and quantitative electroencephalography: a search of neurophysiological markers of cognitive decline in multiple sclerosis 106
Prevalence of JC virus antibodies in human serum and seroconversion rate with first-generation and second generation ELISA: the novel assay improves specificity andsensitivity to detect anti-JC virus antibodies 104
Proteomic investigations on differential post-translational modification of transthyretin in multiple sclerosis. 103
Patient adherence to and tolerability of self-administered interferon beta-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study 94
Progressive multifocal leukoencephalopathy associated with natalizumab in paediatric multiple sclerosis 93
Treatment discontinuation issues in fingolimod treated patients: the Chieti experience. 93
Neuropsychological testing and event-related potentials: markers of cognitive impairment in patients with multiple sclerosis 92
Simultaneous early-onset severe autoimmune hemolytic anemia and albuminuria during alemtuzumab treatment for multiple sclerosis 90
Relation between Pro-inflammatory Cytokines and Acetylcholine Levels in Relapsing-Remitting Multiple Sclerosis Patients 86
Lipidomics analysis reveals low levels of phosphatidylcholines and sphingomyelins in cerebrospinal fluido f multiple sclerosis patients. 77
Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis 75
Spinal cord injury in a patient with multiple sclerosis (MS) with secondary hydromyelia 72
Totale 5.821
Categoria #
all - tutte 20.682
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.682


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202169 0 0 0 0 0 0 0 0 0 25 30 14
2021/2022232 4 4 9 42 9 13 10 20 16 9 24 72
2022/2023757 61 109 43 74 93 133 34 54 104 15 24 13
2023/2024394 17 18 33 6 30 181 48 5 1 8 2 45
2024/2025979 50 103 110 11 23 63 94 52 103 44 164 162
2025/20261.677 163 41 234 246 202 92 307 89 186 117 0 0
Totale 5.821